Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by johnny007on Jun 03, 2021 9:19am
98 Views
Post# 33317857

RE:down the toilet

RE:down the toiletit was most undiplomatic and all that, agreed. You may even say stupid ;-)
Communication with company is in progress not to enact this nonsense RS while we are down this much. In an uptrend, it would be OK, even though I still fail to see its merits.

HOWEVER, compare their balance sheet, cash flow and income over the last quarters and MCAP.

Company is in her best ever situation, financially.
Balance sheet is all green, if you take off the paper liabilities (warrant paper loss).
Same goes for income.

If stock would be traded above C$2, there might be room to short, but not here.
All shorts have covered, now traded with super low volume again.

This surely has room to recover a good chunk now.
Good luck.
<< Previous
Bullboard Posts
Next >>